CMS Clarifies Factors It Will Consider In Negotiating Drug Prices

By Gabrielle Wanneh / September 8, 2023 at 7:28 PM

A new fact sheet released by CMS Friday (Sept. 8) offers more insight into how Medicare’s first round of price negotiations for expensive Medicare Part D drugs will run, coming as drug maker agreements to participate in the program are due Oct. 1.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

CMS Clarifies Factors It Will Consider In Negotiating Drug Prices

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.